Rexahn Pharmaceuticals, Inc. to Present at the Acumen BioFin 9th Annual Healthcare Conference

ROCKVILLE, Md.--(BUSINESS WIRE)--

Rexahn Pharmaceuticals, Inc. (OTCBB:RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, today announced that Chief Financial Officer, Ted Jeong, will be presenting an overview of Rexahn Pharmaceuticals at the Acumen BioFin 9th Annual Healthcare Conference on Monday, November 5, 2007 at 2:00pm Eastern Time at the New York Palace Hotel.

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a biopharmaceutical company leveraging its unique technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy. For Additional information about Rexahn visit www.rexahn.com.

Source: Rexahn Pharmaceuticals, Inc.

Released October 29, 2007